Companies / Germany
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Fresenius Enters Generic Drug Market With APP Pharmaceuticals Acquisition
July 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Germany-based global healthcare company Fresenius SE has agreed to buy US generic intravenous (IV) drug specialist APP Pharmaceuticals in a deal worth an initial US$3.7bn.